How Dual-Action Inhibitors Reprogram p38α Dephosphorylation
2026-08-30
The reference preprint identifies a dual-action mode in which selected kinase inhibitors both occupy the p38α active site and accelerate WIP1-mediated removal of the activation-loop phosphate. Structural data explain this effect as a conformational mechanism, suggesting that kinase inhibitor design can influence signal termination as well as catalytic activity.
Alcian Blue & Nuclear Fast Red Staining Kit pH2.5
2026-08-29
A practical guide to using dual-color acid mucin staining for chondrogenic differentiation, mucopolysaccharide-rich tissues, and clearer cellular morphology. The workflow combines Alcian Blue signal detection with Nuclear Fast Red contrast while addressing small-sample handling, controls, and troubleshooting.
Thiamet G for Reliable Cell Assays
2026-08-29
A scenario-based guide to using Thiamet G (SKU B2048) as an O-GlcNAcase inhibitor in viability, cytotoxicity, tauopathy, leukemia, and trophoblast workflows. It connects product specifications with practical controls for stock preparation, assay interpretation, and vendor selection.
AhR–RBX1/HSF1 Signaling in Acute Pancreatitis
2026-08-28
Fang and colleagues identify aryl hydrocarbon receptor signaling as a regulator of pancreatic tight-junction injury in severe acute pancreatitis, linking AhR to HSF1, RBX1-dependent ubiquitination, and macrophage polarization. The study combines a cerulein/LPS mouse model with primary acinar-cell and macrophage experiments, while pharmacological inhibition with triptolide supports—but does not by itself prove—the proposed pathway.
DiscoveryProbe™ FDA-Approved Drug Library for Stress Biology
2026-08-28
The DiscoveryProbe FDA-approved Drug Library (L1021) enables mechanism-first screening of proteotoxic and oxidative-stress responses. Grounded in the CRTC-CREB study in Drosophila, this guide shows how to connect phenotypic hits with ROS, JNK, transcriptional, and proteostasis readouts.
Wnt Agonist 1: From β-Catenin to Translation
2026-08-27
A translational perspective on Wnt agonist 1 (BML-284), linking controlled β-catenin–TCF activation with differentiation research and the Wnt/NR2F2/GPX4 chemoresistance axis described in lung cancer brain metastasis.
nor-NOHA Acetate in Immunometabolism
2026-08-27
Use nor-NOHA acetate to dissect how arginase-controlled arginine flux influences tumor-cell behavior, nitric oxide biology, and immune assays. This workflow pairs target-engagement measurements with CD36–lipid signaling experiments without overstating an unproven connection between the two metabolic pathways.
DiD for Membrane Tracking in Diabetic Periodontitis
2026-08-26
DiD (DiDC 18 (5)) transforms cell membrane staining into a spatial assay for macrophage migration, adhesion, and tissue interactions in diabetic periodontitis research. This article explains how to pair the red fluorescent membrane probe with ROS, inflammatory, and tissue-repair readouts without confusing membrane location with mitochondrial mechanism.
GW 4869 in Exosome–Osteogenesis Workflows
2026-08-26
GW 4869 provides a practical perturbation strategy for testing whether lithium-engineered BMSC exosomes, rather than soluble signals alone, drive Wnt10a-dependent osteogenesis. This workflow combines neutral sphingomyelinase inhibition with vesicle characterization, cargo analysis, and functional bone-formation assays.
CK2 and ERK8 Inhibitor: Assay Strategy
2026-08-25
Explore how the CK2 and ERK8 inhibitor can function as a small molecule inhibitor for separating kinase-dependent signaling from direct condensate effects. This article translates SARS-CoV-2 nucleocapsid phase-separation research into a rigorous, research-use-only assay framework.
Rosiglitazone Workflows for Adipose Metabolism
2026-08-25
Build cleaner adipocyte experiments with Rosiglitazone (Brl-49653) by separating PPARγ-driven differentiation, insulin sensitivity modulation, and beige-fat thermogenesis. This workflow pairs a defined chemical perturbation with SETD7-focused assays to improve pathway resolution and troubleshooting.
Ibrexafungerp Against Echinocandin-Resistant Candida
2026-08-24
This study evaluates ibrexafungerp, also known as MK 3118, against a large collection of clinically derived echinocandin-resistant Candida isolates. By integrating EUCAST susceptibility testing with FKS hotspot genotyping and wild-type upper limits, the authors show that activity is retained in many resistant isolates, although susceptibility depends on species and mutation location.
LY2228820: p38 MAP kinase inhibitor workflow
2026-08-23
Build mechanism-aware p38 assays around LY2228820 to connect kinase inhibition with MK2, HSP27, cytokine, angiogenesis, and cell-death readouts. The workflow separates direct pathway blockade from altered dephosphorylation, helping anti-inflammatory research and cancer research teams obtain more interpretable results.
PBS (Phosphate-Buffered Saline): Lab Use Guide
2026-08-22
PBS (Phosphate-Buffered Saline, SKU K2818) provides a sterile, isotonic buffer for cell washing, reagent dilution, and routine in vitro workflows requiring a near-physiological pH. It should be used as a research reagent rather than a growth medium, diagnostic material, clinical product, or in vivo preparation.
Brassinolide Workflows for Plant and Cancer Research
2026-08-21
Build reproducible Brassinolide experiments across plant growth assays, PC-3 apoptosis studies, and preclinical metabolic models. This practical guide connects formulation, controls, readouts, and troubleshooting while separating established findings from exploratory workflow recommendations.
462 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page